Lindis Blood Care Establishes Scientific Advisory Board of Leading Industry Experts
Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood Hennigsdorf (Berlin), […]
Lindis Blood Care successfully closes follow-on financing round
Lindis Blood Care successfully closes follow-on financing round Hennigsdorf, Germany – 9th February, 2022. Funding round supported by High-Tech Gründerfonds (HTGF), Brandenburg Kapital […]
Over 5 million euros for Lindis Blood Care
Over 5 million euros for Lindis Blood Care: development of a new product for the removal of tumor cells from surgical blood Hennigsdorf (Berlin), Germany: December 11, 2019. As is standard during tumor surgeries, when large volumes of blood are lost, donor blood is given to the patient. Worldwide, this is the case for more […]